Connection

Kevin Gray to Adolescent

Back to Details
This is a "connection" page, showing publications Kevin Gray has written about Adolescent.
Kevin Gray
Connection Strength
3.135
Adolescent
  1. ADHD symptoms and smoking outcomes in a randomized controlled trial of varenicline for adolescent and young adult tobacco cessation. Drug Alcohol Depend. 2023 03 01; 244:109798.
    View in: PubMed
    Score: 0.087
  2. Cannabis Use Disorder in Adolescents. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):13-20.
    View in: PubMed
    Score: 0.086
  3. Social and community inclusion outcomes for adults with autism with and without intellectual disability in Australia. J Intellect Disabil Res. 2022 07; 66(7):655-666.
    View in: PubMed
    Score: 0.084
  4. Effect of varenicline for smoking cessation in adolescents - Authors' reply. Lancet Child Adolesc Health. 2021 02; 5(2):e4.
    View in: PubMed
    Score: 0.076
  5. Participation in sport and physical activity in adults with intellectual disabilities. J Intellect Disabil Res. 2020 12; 64(12):908-922.
    View in: PubMed
    Score: 0.074
  6. High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trial. Lancet Child Adolesc Health. 2020 11; 4(11):837-845.
    View in: PubMed
    Score: 0.074
  7. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine Tob Res. 2020 07 16; 22(8):1374-1382.
    View in: PubMed
    Score: 0.073
  8. Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2020 01 27; 22(1):81-88.
    View in: PubMed
    Score: 0.071
  9. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. JAMA Pediatr. 2019 12 01; 173(12):1146-1153.
    View in: PubMed
    Score: 0.070
  10. Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies. Curr Psychiatry Rep. 2019 09 14; 21(10):96.
    View in: PubMed
    Score: 0.069
  11. Youth Substance Use: Introduction to the Journal of Child and Adolescent Psychopharmacology Special Issue. J Child Adolesc Psychopharmacol. 2019 08; 29(7):475-476.
    View in: PubMed
    Score: 0.069
  12. Pharmacological Treatment of Youth Substance Use Disorders. J Child Adolesc Psychopharmacol. 2019 08; 29(7):559-572.
    View in: PubMed
    Score: 0.067
  13. Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug Alcohol Depend. 2019 05 01; 198:105-111.
    View in: PubMed
    Score: 0.067
  14. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend. 2018 11 01; 192:59-66.
    View in: PubMed
    Score: 0.064
  15. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine. Addict Behav. 2018 10; 85:26-30.
    View in: PubMed
    Score: 0.063
  16. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug Alcohol Depend. 2018 04 01; 185:17-22.
    View in: PubMed
    Score: 0.062
  17. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7.
    View in: PubMed
    Score: 0.061
  18. Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. J Subst Abuse Treat. 2017 10; 81:53-58.
    View in: PubMed
    Score: 0.060
  19. Research Review: What have we learned about adolescent substance use? J Child Psychol Psychiatry. 2018 06; 59(6):618-627.
    View in: PubMed
    Score: 0.059
  20. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257.
    View in: PubMed
    Score: 0.059
  21. Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend. 2017 07 01; 176:14-20.
    View in: PubMed
    Score: 0.059
  22. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. Addict Behav. 2016 12; 63:172-7.
    View in: PubMed
    Score: 0.056
  23. Alcohol and Drug Use and the Developing Brain. Curr Psychiatry Rep. 2016 May; 18(5):46.
    View in: PubMed
    Score: 0.055
  24. Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood. J Subst Abuse Treat. 2016 07; 66:16-22.
    View in: PubMed
    Score: 0.054
  25. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder. J Subst Abuse Treat. 2016 Apr; 63:72-7.
    View in: PubMed
    Score: 0.053
  26. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine Tob Res. 2015 Apr; 17(4):398-406.
    View in: PubMed
    Score: 0.051
  27. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Addiction. 2015 Jun; 110(6):1027-34.
    View in: PubMed
    Score: 0.051
  28. Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence. Addict Behav. 2015 Jun; 45:119-23.
    View in: PubMed
    Score: 0.050
  29. Objective and subjective memory ratings in cannabis-dependent adolescents. Am J Addict. 2015 Jan; 24(1):47-52.
    View in: PubMed
    Score: 0.050
  30. Association between adaptive behaviour and age in adults with Down syndrome without dementia: examining the range and severity of adaptive behaviour problems. J Intellect Disabil Res. 2015 Aug; 59(8):689-702.
    View in: PubMed
    Score: 0.049
  31. Menstrual cycle phase effects in the gender dimorphic stress cue reactivity of smokers. Nicotine Tob Res. 2015 May; 17(5):607-11.
    View in: PubMed
    Score: 0.049
  32. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23.
    View in: PubMed
    Score: 0.049
  33. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6.
    View in: PubMed
    Score: 0.048
  34. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents. Am J Drug Alcohol Abuse. 2014 Jul; 40(4):285-91.
    View in: PubMed
    Score: 0.047
  35. Craving, cue reactivity, and stimulus control among early-stage young smokers: effects of smoking intensity and gender. Nicotine Tob Res. 2014 Feb; 16(2):208-15.
    View in: PubMed
    Score: 0.046
  36. Smoking topography and abstinence in adult female smokers. Addict Behav. 2013 Dec; 38(12):2833-6.
    View in: PubMed
    Score: 0.045
  37. Outcomes in young adulthood: are we achieving community participation and inclusion? J Intellect Disabil Res. 2014 Aug; 58(8):734-45.
    View in: PubMed
    Score: 0.045
  38. Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial. Addict Behav. 2013 Mar; 38(3):1788-91.
    View in: PubMed
    Score: 0.043
  39. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012 Aug; 169(8):805-12.
    View in: PubMed
    Score: 0.042
  40. Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial. Nicotine Tob Res. 2012 Feb; 14(2):234-9.
    View in: PubMed
    Score: 0.039
  41. Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug Alcohol Depend. 2011 Sep 01; 117(2-3):242-7.
    View in: PubMed
    Score: 0.038
  42. Bupropion SR and contingency management for adolescent smoking cessation. J Subst Abuse Treat. 2011 Jan; 40(1):77-86.
    View in: PubMed
    Score: 0.037
  43. Reactivity to in vivo marijuana cues among cannabis-dependent adolescents. Addict Behav. 2011 Jan-Feb; 36(1-2):140-3.
    View in: PubMed
    Score: 0.037
  44. Attention-deficit/hyperactivity disorder confounds nicotine withdrawal self-report in adolescent smokers. Am J Addict. 2010 Jul-Aug; 19(4):325-31.
    View in: PubMed
    Score: 0.037
  45. N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict. 2010 Mar-Apr; 19(2):187-9.
    View in: PubMed
    Score: 0.036
  46. Cue reactivity in young marijuana smokers: a preliminary investigation. Psychol Addict Behav. 2008 Dec; 22(4):582-6.
    View in: PubMed
    Score: 0.033
  47. Tolerability and effects of oral Delta9-tetrahydrocannabinol in older adolescents with marijuana use disorders. Pharmacol Biochem Behav. 2008 Nov; 91(1):67-70.
    View in: PubMed
    Score: 0.032
  48. Advances in diagnosis of adolescent substance abuse. Adolesc Med Clin. 2006 Jun; 17(2):411-25.
    View in: PubMed
    Score: 0.028
  49. Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial. BMC Psychol. 2023 Jan 25; 11(1):25.
    View in: PubMed
    Score: 0.022
  50. Characterization of Salivary Progesterone in Female Smokers. Nicotine Tob Res. 2022 10 26; 24(11):1829-1833.
    View in: PubMed
    Score: 0.021
  51. Distress tolerance and reactivity to negative affective cues in naturalistic environments of cannabis-using emerging adults. Drug Alcohol Depend. 2022 09 01; 238:109588.
    View in: PubMed
    Score: 0.021
  52. A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth. Drug Alcohol Depend. 2022 03 01; 232:109311.
    View in: PubMed
    Score: 0.020
  53. Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) study. Drug Alcohol Depend. 2021 10 01; 227:108946.
    View in: PubMed
    Score: 0.020
  54. Rates of Incidental Findings in Brain Magnetic Resonance Imaging in Children. JAMA Neurol. 2021 05 01; 78(5):578-587.
    View in: PubMed
    Score: 0.019
  55. Correspondence Between Perceived Pubertal Development and Hormone Levels in 9-10 Year-Olds From the Adolescent Brain Cognitive Development Study. Front Endocrinol (Lausanne). 2020; 11:549928.
    View in: PubMed
    Score: 0.019
  56. Coercive parenting: modifiable and nonmodifiable risk factors in parents of children with developmental disabilities. J Intellect Disabil Res. 2021 04; 65(4):306-319.
    View in: PubMed
    Score: 0.019
  57. Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study. Addict Biol. 2021 03; 26(2):e12918.
    View in: PubMed
    Score: 0.018
  58. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
    View in: PubMed
    Score: 0.018
  59. The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm. Psychopharmacology (Berl). 2020 Feb; 237(2):543-555.
    View in: PubMed
    Score: 0.018
  60. Unconscious Bias and the Diagnosis of Disruptive Behavior Disorders and ADHD in African American and Hispanic Youth. Acad Psychiatry. 2020 Feb; 44(1):95-102.
    View in: PubMed
    Score: 0.017
  61. Brain iron levels in attention-deficit/hyperactivity disorder normalize as a function of psychostimulant treatment duration. Neuroimage Clin. 2019; 24:101993.
    View in: PubMed
    Score: 0.017
  62. Image processing and analysis methods for the Adolescent Brain Cognitive Development Study. Neuroimage. 2019 11 15; 202:116091.
    View in: PubMed
    Score: 0.017
  63. Preliminary evidence that computerized approach avoidance training is not associated with changes in fMRI cannabis cue reactivity in non-treatment-seeking adolescent cannabis users. Drug Alcohol Depend. 2019 07 01; 200:145-152.
    View in: PubMed
    Score: 0.017
  64. Investigating a novel fMRI cannabis cue reactivity task in youth. Addict Behav. 2019 02; 89:20-28.
    View in: PubMed
    Score: 0.016
  65. A multi-site proof-of-concept investigation of computerized approach-avoidance training in adolescent cannabis users. Drug Alcohol Depend. 2018 06 01; 187:195-204.
    View in: PubMed
    Score: 0.016
  66. Current, future and potential use of mobile and wearable technologies and social media data in the ABCD study to increase understanding of contributors to child health. Dev Cogn Neurosci. 2018 08; 32:121-129.
    View in: PubMed
    Score: 0.016
  67. Concurrence of the strengths and difficulties questionnaire and developmental behaviour checklist among children with an intellectual disability. J Intellect Disabil Res. 2018 02; 62(2):150-155.
    View in: PubMed
    Score: 0.015
  68. Parents of Children with ASD Experience More Psychological Distress, Parenting Stress, and Attachment-Related Anxiety. J Autism Dev Disord. 2016 Sep; 46(9):2979-91.
    View in: PubMed
    Score: 0.014
  69. A cross-syndrome evaluation of a new attention rating scale: The Scale of Attention in Intellectual Disability. Res Dev Disabil. 2016 Oct; 57:18-28.
    View in: PubMed
    Score: 0.014
  70. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology. 2016 07; 41(8):1974-82.
    View in: PubMed
    Score: 0.013
  71. Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict. 2016 Jan; 25(1):69-75.
    View in: PubMed
    Score: 0.013
  72. Multimodal MR imaging of brain iron in attention deficit hyperactivity disorder: a noninvasive biomarker that responds to psychostimulant treatment? Radiology. 2014 Aug; 272(2):524-32.
    View in: PubMed
    Score: 0.012
  73. Affective motives for smoking among early stage smokers. Nicotine Tob Res. 2014 Oct; 16(10):1387-93.
    View in: PubMed
    Score: 0.012
  74. Cigarette warning label policy alternatives and smoking-related health disparities. Am J Prev Med. 2012 Dec; 43(6):590-600.
    View in: PubMed
    Score: 0.011
  75. Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol. 2012 Aug; 20(4):251-7.
    View in: PubMed
    Score: 0.010
  76. Behavioural and emotional problems in people with severe and profound intellectual disability. J Intellect Disabil Res. 2011 Feb; 55(2):190-8.
    View in: PubMed
    Score: 0.009
  77. Assessment of nicotine dependence among adolescent and young adult smokers: a comparison of measures. Addict Behav. 2010 Nov; 35(11):977-82.
    View in: PubMed
    Score: 0.009
  78. Evidence for greater cue reactivity among low-dependent vs. high-dependent smokers. Addict Behav. 2010 Jul; 35(7):673-7.
    View in: PubMed
    Score: 0.009
  79. Laboratory-based, cue-elicited craving and cue reactivity as predictors of naturally occurring smoking behavior. Addict Behav. 2009 Jun-Jul; 34(6-7):536-41.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.